Lepermislibre SA
F:I5T
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
Lepermislibre SA
F:I5T
|
FR |
|
Z
|
Zurich Insurance Group AG
XMUN:ZFIN
|
CH |
|
Intesa Sanpaolo SpA
OTC:IITSF
|
IT |
|
H
|
Healthequity Inc
F:2HE
|
US |
|
Mitsubishi Electric Corp
TSE:6503
|
JP |
|
Z
|
Zurich Insurance Group AG
DUS:ZFIN
|
CH |
|
S
|
Schneider Electric SE
DUS:SND
|
FR |
|
B
|
Baidu Inc
SGX:K3SD
|
CN |
|
H
|
Hebei Yichen Industrial Group Corp Ltd
F:HE2
|
CN |
|
P
|
Papa John's International Inc
F:PP1
|
US |
|
Gap Inc
NYSE:GAP
|
US |
|
NovaBay Pharmaceuticals Inc
F:B9P
|
US |
|
Tubacex SA
F:TCX
|
ES |
|
C
|
CNH Industrial NV
XMUN:37C
|
UK |
|
R
|
Raytheon Technologies Corp
F:5UR
|
US |
|
C
|
Credit Agricole SA
XBER:XCA
|
FR |
|
O
|
Omnicom Group Inc
F:OCN
|
US |
|
OMV AG
SIX:OMV
|
AT |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is I5T's stock price target?
Not Available
I5T does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Lepermislibre SA?
Projected CAGR
5%
Over the last 3 years, the compound annual growth rate for Revenue has been 2%. The projected CAGR for the next 2 years is 5%.